Phase II Safety Study of 2 Dose Regimens of HepaStem in Patients With ACLF

Clinical trial NCT02946554 · COMPLETED

Trial details

NCT number: NCT02946554
Sponsor: Cellaion SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute-On-Chronic Liver Failure

Start date: 2016-12-01
Primary completion: 2019-07-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.